Respiratory Tract Diseases

568 trials 207 recruiting

Filter these 568 trials by phase, country and sponsor.

Open in Search →

A study to find out whether BI 1015550 improves lung function in people with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) Ended

2024-512803-37-00 Progressive Fibrosing Interstitial Lung Diseases (PF-IL 5 2022-10-05
COPD - Eosinophil-guided Reduction of Inhaled Corticosteroids (COPERNICOS) Ended

2022-501035-16-01 Chronic obstructive pulmonary disease (COPD) 6 2022-08-23
Phase-II randomized clinical trial to evaluate the effect of Loratadine associated with Rapamune on Lymphagioleiomyomatosis (LAM). Ended

2024-516808-42-00 Effect of loratadine in patients with lymphangioleiomyo 4 2022-08-18
Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dependent Asthma Ended

2023-504648-33-00 Oral Corticosteroid Dependent Asthma 5 2022-07-19
Treprostinil Palmitil Inhalation Powder for Pulmonary Arterial Hypertension Ended

2023-505541-99-00 Pulmonary Arterial Hypertension 4 2022-06-28
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of RO7303509 in Patients with Systemic Sclero… Ended

2022-502981-26-00 Systemic Sclerosis 3 2022-06-27
Mechanistic study of the effect of itepekimab on airway inflammation in patients with COPD Ended

2024-512007-39-00 Chronic Obstructive Pulmonary Disease 4 2022-06-20
A Study to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects with Idiopathic Pulmonary Fibrosis Ended

2023-509784-24-00 Idiopathic Pulmonary Fibrosis 4 2022-05-11
A study comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF5993 With the Fixed Dose Dual Combination CHF153… Ended

2023-510172-31-00 Chronic obstructive pulmonary disease (COPD) 5 2022-04-22
A study to evaluate long-term safety of nintedanib in children and adolescents with interstitial lung disease (InPedILD®-ON) Ended

2024-515743-27-00 Childhood Interstitial Lung Disease 5 2022-04-04
Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Subjects 2 Years and Older Ended

2024-515606-90-00 Cystic Fibrosis 5 2022-04-01
AcTIVE - ACid tranexamic or Terlipressin for Initial emergency treatment of mild to seVere hEmoptysis: a randomized Trial Ended

2024-515010-40-00 Hemoptysis, whatever the cause, with the exception of c 5 2022-03-28
Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler in Patients with Inadequately Controlled Asthma Ended

2024-513568-24-00 Inadequately Controlled Asthma 5 2022-03-23
Potential of FX06 to improve disease severity in Acute Respiratory Distress Syndrome patients (Ixion 2.0) Ended

2024-519104-27-00 Acute Respiratory Distress Syndrome (ARDS) 4 2022-03-08
Study to assess efficacy, safety, and tolerability of Tozorakimab in patients with symptomatic chronic obstructive pulmonary disease (COPD) … Ended

2023-503572-24-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2022-03-02
Tiotropium in preventing preschool asthma (TIPP) Ended

2024-513916-84-00 Severe asthma exacerbations in partial and uncontrolled 5 2022-02-18
A Study to Evaluate the Efficacy and Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Ended

2023-507093-40-00 Chronic Obstructive Pulmonary Disease (COPD) 4 2022-01-27
Study to assess efficacy, safety, and tolerability of Tozorakimab in patients with symptomatic chronic obstructive pulmonary disease (COPD) … Ended

2023-503571-19-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2022-01-20
Study of the use of the drug Thymosin alpha 1 in adults patients with Cystic Fibrosis. Ended

2024-518102-41-00 Cystic Fibrosis 4 2021-12-07
A Study of Baricitinib (LY3009104) in Children With COVID-19 (COV-BARRIER) Ended

2024-516824-32-00 Covid19 Corona Virus Infection 5 2021-11-15
Evaluation of frequency occurrence persistent pulmonary hypertension of newborns treated by salbutamol Ended

2024-515216-46-00 Breathing disorders as a cause of neonatal respiratory 11 2021-11-15
A study to evaluate the efficacy and safety of repeating dose of benralizumab administered SC versus placebo in patients with Eosinophilic C… Ended

2023-507987-38-00 Severe CRSwNP patients with asthma. 5 2021-10-14
A study of GSK3511294 (Depemokimab) in participants who were previously enrolled in 206713 or 213744; Open-Label Extension Ended

2023-505203-23-01 Severe asthma with an eosinophilic phenotype 5 2021-07-26
Access to Pirfenidone Solution for Inhalation (AP01) for Treatment of Progressive, Fibrosing Interstitial Lung Diseases, including Idiopathi… Ended

2024-515964-30-00 Interstitial Lung Diseases (ILD), including but not lim 4 2021-07-14